New England Capital Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Buy |
412
+5
| +1% | +$192 | 0.01% | 202 |
|
|
2025
Q1 | $15.8K | Buy |
407
+3
| +0.7% | +$116 | 0.01% | 201 |
|
|
2024
Q4 | $13.7K | Buy |
404
+162
| +67% | +$5.48K | 0.01% | 209 |
|
|
2024
Q3 | $9.89K | Buy |
242
+2
| +0.8% | +$82 | 0.01% | 234 |
|
|
2024
Q2 | $9.23K | Buy |
240
+3
| +1% | +$115 | 0.01% | 228 |
|
|
2024
Q1 | $10.2K | Buy |
237
+2
| +0.9% | +$86 | 0.01% | 225 |
|
|
2023
Q4 | $8.72K | Buy |
235
+2
| +0.9% | +$74 | 0.01% | 237 |
|
|
2023
Q3 | $8.45K | Buy |
233
+2
| +0.9% | +$73 | 0.01% | 236 |
|
|
2023
Q2 | $8.23K | Buy |
231
+1
| +0.4% | +$36 | 0.01% | 240 |
|
|
2023
Q1 | $8.17K | Buy |
230
+100
| +77% | +$3.55K | 0.01% | 266 |
|
|
2022
Q4 | $4.59K | Buy |
+130
| New | +$4.59K | ﹤0.01% | 303 |
|